Skip to main content
. 2017 Apr 10;8(25):41044–41063. doi: 10.18632/oncotarget.17008

Table 2. Molecular characteristics of pNET primary cultures.

Tumor (number) Grade SST2R (copies/copies GUSβ) CgA secretion
Control (U/l) octreotide (%inhibition)
1 G2 2.80 325 ± 9 28 ± 1**
2 G1 4.94 170 ± 5 8 ± 5
3 G2 1.57 159 ± 1 49 ± 10*
4 G1 6.67 3941 ± 13 51 ± 4**
5 G2 ND ND ND
6 G3 0.32 10 ± 1 44 ± 7*
7 G1 5.08 137 ± 6 93 ± 1***
8 G2 0.96 49 ± 1 34 ± 11*
9 G2 1.62 40 ± 2 39 ± 2**
10 G2 0.50 488 ± 10 72 ± 1*
11 G2 0.53 21 ± 2 37 ± 6*
12 G2 2.23 514 ± 11 71 ± 1***
13 G2 0.88 870 ± 125 63 ± 2**
14 G2 2.75 569 ± 48 16 ± 2*
15 G3 7.62 284 ± 13 93 ± 2**
16 G2 0.96 691 ± 87 76 ± 10*
17 G2 3.65 93 ± 19 47 ± 6*
18 G2 3.94 66 ± 2 36 ± 4**
19 G1 2.35 735 ± 33 36 ± 15*
20 G1 ND ND ND
21 G1 3.23 16 ± 2 49 ± 9*
22 G1 2.67 568 ± 21 85 ± 1***
23 G3 1.11 ND ND
24 G3 0.50 ND ND
25 G2 6.92 ND ND

SST2 receptor mRNA was determined as described in patients and methods by real-time PCR. Cells were treated in the absence or in the presence of 1nM octreotide and CgA secretion was measured as described in patients and methods. (*) p<0.05; (**) p<0.01 (***) p<0.001 versus control conditions.